News

Malaria Prophylaxis: Destination Designates Drug

Publish date: April 21, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF PHYSICIANS

Dr. Miller reported having financial relationships with Pfizer, Cubist Pharmaceuticals, GlaxoSmithKline, and Merck. He has been a consultant with Theravance.

Pages

Recommended Reading

FDA Approves Shingles Vaccine for Ages 50-59
MDedge Dermatology
Enhanced Cleaning Reduces MRSA, Harder to Reduce VRE
MDedge Dermatology
Action Urged Against Growing Antimicrobial Resistance
MDedge Dermatology
Scarring Alopecia in Black Women Still Not Understood
MDedge Dermatology
Topical Suffocants Effective for Resistant Head Lice
MDedge Dermatology
Alternative Dosing Schedules for HPV Vaccine Found Effective
MDedge Dermatology
FDA Sends Warning Letters to Four Hand Sanitizer Manufacturers
MDedge Dermatology
Nonhealing Scalp Wound Infected With Aspergillus niger in an Elderly Patient
MDedge Dermatology
What's Eating You? Hyalomma Ticks
MDedge Dermatology
What Is Your Diagnosis? Molluscum Contagiosum on the Sole of the Foot
MDedge Dermatology